These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21330475)

  • 1. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli.
    Chatterjee M; Huang Z; Zhang W; Jiang L; Hultenby K; Zhu L; Hu H; Nilsson GP; Li N
    Blood; 2011 Apr; 117(14):3907-11. PubMed ID: 21330475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
    Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
    J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
    Bambace NM; Levis JE; Holmes CE
    Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Effects of Platelets Selectively Activated by Protease-Activated Receptors on Meniscal Cells.
    Xu H; Zou X; Xia P; Aboudi MAK; Chen R; Huang H
    Am J Sports Med; 2020 Jan; 48(1):197-209. PubMed ID: 31765237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.
    Ma L; Perini R; McKnight W; Dicay M; Klein A; Hollenberg MD; Wallace JL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(1):216-20. PubMed ID: 15615851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
    Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
    Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4.
    Walsh TG; Harper MT; Poole AW
    Cell Signal; 2015 Jan; 27(1):37-46. PubMed ID: 25283599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
    Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
    PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
    Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
    Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin.
    Etulain J; Fondevila C; Negrotto S; Schattner M
    Br J Pharmacol; 2013 Sep; 170(2):255-65. PubMed ID: 23713888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
    Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
    Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
    Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.
    Ma L; Elliott SN; Cirino G; Buret A; Ignarro LJ; Wallace JL
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6470-5. PubMed ID: 11353854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
    Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets.
    van Holten TC; Bleijerveld OB; Wijten P; de Groot PG; Heck AJ; Barendrecht AD; Merkx TH; Scholten A; Roest M
    Cardiovasc Res; 2014 Jul; 103(1):140-6. PubMed ID: 24776597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet phenotype changes associated with breast cancer and its treatment.
    Holmes CE; Levis JE; Schneider DJ; Bambace NM; Sharma D; Lal I; Wood ME; Muss HB
    Platelets; 2016 Nov; 27(7):703-711. PubMed ID: 27135253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.
    Ma L; Hollenberg MD; Wallace JL
    Br J Pharmacol; 2001 Oct; 134(4):701-4. PubMed ID: 11606309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation.
    Nakashima D; Onuma T; Tanabe K; Kito Y; Uematsu K; Mizutani D; Enomoto Y; Tsujimoto M; Doi T; Matsushima-Nishiwaki R; Tokuda H; Ogura S; Iwama T; Kozawa O; Iida H
    PLoS One; 2020; 15(10):e0241139. PubMed ID: 33119719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.